Memorial Sloan Kettering Cancer Center (US)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
127
Publications
1899
Citations
107750
i10-index
757
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Increased Survival with Enzalutamide in Prostate C... | 2012 | 4543 |
Abiraterone and Increased Survival in Metastatic P... | 2011 | 4369 |
Enzalutamide in Metastatic Prostate Cancer before ... | 2014 | 3005 |
Abiraterone in Metastatic Prostate Cancer without ... | 2012 | 2766 |
Olaparib for Metastatic Castration-Resistant Prost... | 2020 | 2176 |
A Randomized, Placebo-Controlled Trial of Zoledron... | 2002 | 1654 |
Abiraterone acetate for treatment of metastatic ca... | 2012 | 1375 |
Abiraterone acetate plus prednisone versus placebo... | 2015 | 1334 |
Apalutamide Treatment and Metastasis-free Survival... | 2018 | 1307 |
Denosumab in Men Receiving Androgen-Deprivation Th... | 2009 | 1122 |
Fred Saad is a researcher with 1899 publications and 107750 citations. They are affiliated with Memorial Sloan Kettering Cancer Center. Their research focuses on . With an h-index of 127, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Fred Saad and 250M+ other papers.
Citations per publication by year